AstraZeneca says could begin COVID-19 vaccine production early in 2021
- World
- Reuters
- Published Date: 04:26 | 13 August 2020
- Modified Date: 04:26 | 13 August 2020
Production of a COVID-19 vaccine under an agreement between the Mexican and Argentine governments and pharmaceutical company AstraZeneca could begin in the first quarter of 2021, an AstraZeneca executive said on Thursday.
Sylvia Varela, head of AstraZeneca Mexico, said at the Mexican president's daily news conference that Phase III trials were expected to conclude by November or December.
- France and Netherlands added to UK travel quarantine list
- Brazil death toll from COVID-19 passes 105,000
- Top U.S. health official says COVID vaccines unlikely to be approved before November
- Virus-hit Mexico City reopens museums, cinemas
- Clinton says she hopes Harris gets 'less sexist' treatment on U.S. campaign trail